phase readout
saveNCT05344443: Lemborexant Shift Work Treatment Study
COMPLETEDupdated 5mo ago
community read0 votes
Sponsor: University of California, San Francisco. Phase: PHASE4. Conditions: Shift-Work Related Sleep Disturbance
view source ↗Data sources
last refreshed 2h ago
Found something off?
same company · ±60 days · 6
- grantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Analyzing the Distribution, Effectiveness, and Implementation of Wildfire Smo...Apr 17, 2026
- grantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Assessing multi-site feasibility of an integrated whole-body hyperthermia and...Apr 17, 2026
- grantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Leveraging a Novel Neural Circuit for Urinary and Fecal IncontinenceApr 15, 2026
- grantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Transcriptional Mechanisms that Catalyze Dysregulated Type 17 Mucosal Inflamm...Apr 15, 2026
- grantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — CARE: Community Action Research for Equity – Understanding care and decision ...Apr 10, 2026
- grantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Advancing Analytical Tools to Quantify and Mitigate the Risk for Transitionin...Apr 10, 2026
related news · 5
- statSTAT+: A geriatrician explains why AI for older adults deserves careful scrutiny
- fiercebiotechResearch into protein interactions sheds new light on causes of autism
- statFDA panel confronting peptide controversy
- oncliveCapivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Cancer
- statSTAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics center
comments(0)
5-min edit window · permanent after that